ÕÒÂÛÎÄÍø > ҽҩѧÂÛÎÄ > ҽѧÂÛÎÄ >

ÄͶàÒ©½áºË·ÖÖ§¸Ë¾ú»ùÒòÍ»±äÔÚÄÍÒ©ÐÔ¼ì²âÖеÄÓ¦ÓÃ(1)

¡¾ÕªÒª¡¿  Ä¿µÄ  ̽ÌÖÄͶàÒ©½áºË²¡£¨MDR-TB£©ÁÙ´²·ÖÀëÖêrPOB¡¢KatGºÍrpsL»ùÒòÍ»±äÔÚÄÍÒ©ÐÔ¼ì²âÖеÄÓ¦ÓüÛÖµ¡£·½·¨  ²ÉÓþۺÏøÁ´·´Ó¦-µ¥Á´¹¹Ïó¶à̬ÐÔ£¨PCR-SSCP£©¼¼Êõ·ÖÎöÁË54ÖêͬʱÄÍÒìÑÌ루INH£©¡¢Àû¸£Æ½£¨RFP£©¡¢Á´Ã¹ËØ£¨SM£©µÄ¶àÄÍÒ©ÁÙ´²·ÖÀëÖêºÍ45ÖêÒ©ÎïÃô¸ÐÖêµÄrPOB¡¢KatG¡¢rpsL»ùÒòÍ»±ä¡£½á¹û  ÒÔ½áºË·ÖÖ§¸Ë¾úH37RVΪ¶ÔÕÕ£¬45ÖêÒ©ÎïÃô¸ÐÖêµÄrPOB¡¢rpsL»ùÒòSSCPͼÆ×Õý³££¬ÆäÌØÒìÐÔΪ100%£»KatG»ùÒòÓÐ2ÖêͼÆ×Òì³££¬ÌØÒìÐÔΪ95.6%¡£89Öê½áºË·ÖÖ§¸Ë¾úÁÙ´²·ÖÀëÖê¾ùδ·¢ÏÖrPOB¡¢KatG¡¢rpsL»ùÒòȱʧ£¬ÆäPCRÀ©Ôö²úÎïSSCP·ÖÎö½á¹û±íÃ÷£º54Öê¶àÄÍÒ©ÁÙ´²·ÖÀëÖêÖУ¬49ÖêrPOB»ùÒòͼÆ×Òì³££»32ÖêKatG»ùÒòͼÆ×Òì³££»40ÖêrpsL»ùÒòͼÆ×Òì³£¡£ÆäÃô¸ÐÐÔ·Ö±ðΪrPOB(90.7%)¡¢KatG(59.3%)£¬rpsL(74.1%)¡£½áÂÛ  ½áºË·ÖÖ§¸Ë¾úÄÍRFP¡¢INH¡¢SMÄÍÒ©ÐԵIJúÉúÖ÷ÒªÊÇÓÉÓÚrPOB¡¢KatGºÍrpsL»ùÒòÍ»±äËùÖ¡£PCR-SSCP¼¼ÊõÓÐÍû³ÉΪ½áºË·ÖÖ§¸Ë¾úÄÍÒ©ÐÔ¼ì²âµÄ·½·¨Ö®Ò»¡£

    ¡¾¹Ø¼ü´Ê¡¿  ½áºË·ÖÖ§¸Ë¾ú£»rPOB»ùÒò£»KatG»ùÒò£»rpsL»ùÒò£»SSCP£»Ò©ÎïÄÍÊÜÐÔ

     Studies of Mycobacterium tuberculosis multi-drug resistant gene

    ¡¾Abstract¡¿  Objective  To evaluat the importance of rPOB¡¢KatG and rpsL gene mutation detection in multi-drug resistant clinical isolates of Mycobacterium tuberculosis. Methods  rPOB¡¢KatG and rpsL gene mutation of 54multi-drug resistant clinical isolates£¬which is INH RFP and Sm resistance and 54 drug susceptible strains were analyzed using polymerase chain reaction-single strand conformation (PCR-SSCP).Results  SSCP pattern of H37RV strain as control£¬SSCP pattern of rPOB£¬rpsL PCR amplification from drug susceptible strains  were all  the same as control. The specificity was 100%. However£¬the different  SSCP pattern of KatG gene were found in 2 susceptible strains. The specificity was 96.3%. Gene deletion of rPOB¡¢KatG and rpsL were not found in all clinical isolates tested. SSCP patterns of  rPOB gene were different from control in 49 drug resistant clinical isolates.  SSCP patterns of KatG gene were different from control in 32drug resistant clinical isolates£¬SSCP pattern of rpsL gene   were  different  from  control  in  40  drug  resistant  clinical  isolates.  The sensitivity   were 90.1% (rPOB)£¬59.3% (KatG) and rpsl (74.1%)£¬respectively. Conclusion  The major mechanism of RFP£¬INH£¬SM resistant drug was rPOB¡¢KatG and rpsL gene mutation£¬respectively PCR-SSCP may be one of the way which applied to drug resistant detection of Mycobacterium tuberculosis.

    ¡¾Key words¡¿  Mycobacterium tuberculosis£»rPOB gene£»KatG gene£»rpsL gene£»SSCP£»drug  tolerance

    ÎÒ¹úÊǽáºË²¡ÒßÇé×îÑÏÖØµÄ¹ú¼ÒÖ®Ò»£¬ÆäÖ÷ÒªÔ­ÒòÊÇÄÍÒ©£¨DR-TB£©ºÍÄͶàÒ©£¨MDR-TB£©½áºË²¡µÄ¹ã·º·Ö²¼ºÍѸËÙ´«²¥¡£ÓÉÓÚµ¥Ò©»¯ÁƺͲ»¹æÔò»¯ÁÆ£¬ÆäÄÍÒ©Çé¿öÔ½À´Ô½ÑÏÖØ¡£½üÄêÀ´Ëæ×Å·Ö×ÓÉúÎïѧµÄÑо¿½øÕ¹ÈËÃǶԿ¹½áºË·ÖÖ¦¸Ë¾úµÄÒ©Àí×÷ÓÃλµãºÍ½áºË·ÖÖ¦¸Ë¾úÄÍÒ©»úÖÆ£¬ÓÈÆäÊÇÄÍÒìÑÌë¡¢Àû¸£Æ½ºÍÁ´Ã¹ËØ¡£Ä¿Ç°£¬½áºË·ÖÖ§¸Ë¾úÄÍÒ©ÐԲⶨÈÔ¶à²ÉÓþø¶ÔŨ¶È·¨¡¢±ÈÀý·¨µÈ¾­µä·½·¨¡£µ«ÓÉÓÚ½áºË·ÖÖ§¸Ë¾úÉú³¤»ºÂý£¬¶øÄÍÒ©½áºË·ÖÖ§¸Ë¾úÉú³¤¸üΪ»ºÂý£¬ÆäÄÍÒ©ÐԲⶨÐè6¡«8ÖÜÉõÖÁ¸ü³¤£¬²»Äܼ°Ê±Ö¸µ¼ÁÙ´²ÓÃÒ©¡£Ð½ø¿ªÕ¹µÄBactec·¨Ò©Ãô¼ì²âÒòÆä¼Û¸ñ°º¹óµÈÖî¶à²»±ãÏÞÖÆÁËÆä¹ã·ºÊ¹Ó᣾ݱ¨µÀ£Û1£ÝINHÄÍÒ©Óë¹ýÑõ»¯Çâø-¹ýÑõ»¯ÎïøµÄ±àÂë»ùÒò£¨KatG£©Óйء¢¶øÄ³Ð©½áºË·ÖÖ§¸Ë¾úÄÍSMµÄ²úÉúÊÇÓÉÓÚÆäºËÌÇÌåµ°°×S12±àÂë»ùÒò£¨rpsL£©ºÍ16SrRNA±àÂë»ùÒò£¨rrs£©Í»±äËùÖ£Û2£Ý£¬Í¬Ê±Ò²Ö¤ÊµÁ˽áºË·ÖÖ§¸Ë¾úÄÍÀû¸£Æ½ÓëRNA¾ÛºÏøµÄ¦ÂÑÇ»ùµÄ±àÂë»ùÒòrPOBµÄÍ»±äÓйأÛ3£Ý¡£±ÊÕß²ÉPCR-SSCPÒøÈ¾·¨¶Ô54Àý£¨Í¬Ê±ÄÍINH¡¢RFP¡¢SM£©ºÍ45Àý£¨Ò©ÎïÃô¸Ð£©·Î½áºË²¡ÈË̵±ê±¾ÁÙ´²·ÖÀëÖêͬʱ½øÐÐKatG»ùÒò¡¢rPOB»ùÒòºÍrpsL»ùÒòÍ»±ä·ÖÎö¡£

    1  ²ÄÁÏÓë·½·¨

    1.1  ¾úÖêÀ´Ô´  H37RV±ê×¼ÖêÀ´Ô´ÓÚÖйúÒ©Æ·ÉúÎïÖÆÆ·¼ì¶¨Ëù£¬45ÀýÃô¸ÐÖêºÍ54ÀýͬʱÄÍINH¡¢RFP¡¢SMµÄÁÙ´²·ÖÀëÖêÀ´×ÔÖ麣ÊÐÈËÃñÒ½Ôº¡¢ÉòÑôÊÐÐØ¿ÆÒ½ÔºµÈ¡£°´½áºË²¡Õï¶Ïϸ¾úѧ¹æ³Ì½øÐоúÖÖ¼ø¶¨¼°Ò©ÃôÊÔÑé֤ʵΪ½áºË·ÖÖ§¸Ë¾ú£¬ÄÍÒ©ÖêÔòͬʱ¶ÔÒìÑÌë¡¢Àû¸£Æ½¡¢Á´Ã¹ËØÄÍÒ©¡£Ò©ÎïµÄ×î¸ßŨ¶ÈΪÒìÑÌëÂ10mg/L¡¢Àû¸£Æ½250mg/L¡¢Á´Ã¹ËØ100mg/L¡£

    1.2  ·½·¨

    1.2.1  ϸ¾úDNAÖÆ±¸  ÁÙ´²·ÖÀëÖêDNAÓ󣹿·Ó/ÂÈ·ÂÌáÈ¡£¬²¢½«´¿»¯ºóµÄÌáÈ¡ÎïÖÃÓÚ£­20¡æ±£´æ±¸Óá£

    1.2.2  PCRÀ©Ôö  ²ÉÓÃ25¦Ìl·´Ó¦Ìåϵ£¬4xdNTPsÖÕŨ¶ÈΪ0.2mmol/L£¬ÒýÎïÖÕŨ¶ÈΪ0.2¦Ìmol/L£¬ÖÃDNAÀ©ÔöÒÇÀ©Ôö£¬À©Ôö²úÎï¾­2%ÇíÖ¬ÌÇÄý½ºµçÓ¾¡£×ÏÍâ¼ì²ârPOB³öÏÖ258bpÌõ´ø¡¢KatG³öÏÖ282bpÌõ´ø¡¢rpsL³öÏÖ267bpÌõ´ø¼´ÎªÀ©ÔöÑôÐÔ¡£

    1.2.3  SSCPÒøÈ¾  PCRÀ©ÔöÑôÐԵı걾½øÐÐSSCP¼ì²â£¬À©Ôö²úÎï¼ÓµÈÁ¿¼×õ£°·±äÐÔÒº95¡æ±äÐÔ10min£¬Á¢¼´±ùÔ¡5min£¬ÔÚ8%·Ç±äÐÔ¾Û±ûÏ©õ£°·Äý½ºÖеçÓ¾£¬Ìõ¼þΪ6¡æ¡¢100Vµçѹ£¬µçÓ¾Ô¼2¡«3h£¬µçÓ¾½áÊøºó£¬È¡Äý½º°åÐÐÏõËáÒøÈ¾É«£¬¹Û²ì½á¹û²¢ÕÕÏà¡£

¹²2Ò³: 1 [2] ÏÂÒ»Ò³


Ò»ÆðÁ÷ÐÐÐÔÈùÏÙÑ×±©·¢µÄÁ÷Ðв¡Ñ§µ÷²é·ÖÎö
´«È¾¿Æ»¤Ê¿Ö°Òµ±©Â¶µÄΣÏÕÒòËØ¼°Æä·À·¶´ëÊ©
¹¤É̹ÜÀí | ¹¤¿ÆÂÛÎÄ | ²ÆÎñ¹ÜÀí | ¹ÜÀíѧ | ¹«¹²¹ÜÀí | ²ÆÕþ˰ÊÕ | ֤ȯ½ðÈÚ | »á¼ÆÉó¼Æ | ¼ÆËã»ú | ·¨ÂÉÂÛÎÄ | ҽҩѧ | ººÓïÑÔÎÄѧ
Éç»áÂÛÎÄ | ¹¤¿ÆÂÛÎÄ | Àí¿ÆÂÛÎÄ | ÎÄ»¯ÂÛÎÄ | ÒÕÊõÂÛÎÄ | ÎÄѧÂÛÎÄ | ÕÜѧÂÛÎÄ | ÕþÖÎÂÛÎÄ | Ó¢ÓïÂÛÎÄ | д×÷Ö¸µ¼ | ¼ÆËã»úÓ¦ÓÃ
www.zlunwen.com ÕÒÂÛÎÄÍø ® °æÈ¨ËùÓÐ ÍøÕ¾µØÍ¼